Dantari is a Los Angeles area company based on cutting edge science from one of the region’s foremost academic institutions, established to meet a profound unmet need in human therapeutics.
Employees: 11-50
Total raised: $47M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Corner Ven... | cornervent... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.12.2022 | Series A | $47M | - |
Mentions in press and media 4
| Date | Title | Description |
| 08.12.2022 | Dantari Raises $47M in Series A Funding | Richard A. Markus, MD, PhD, Dantari’s president and CEO Dantari, a Thousand Oaks, CA-based clinical-stage biotechnology company, raised $47M in Series A funding. The round was led by Westlake Village BioPartners with participation from Corn... |
| 08.12.2022 | Dantari Gets $47M For Tumor Medicine Effort | Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. The company said ... |
| - | This Week in ‘Raises’: Drata Secures $200M, Dantari Lands $47M | Security and compliance automation platform Drata received new funding to continue investing in research and development (R&D) to build its enterprise grade, automation solution. While biotechnology company Dantari will use its funds to... |
| - | Dantari | - |